Therapeutic interfering particles against HIV: molecular parasites reducing viremia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Therapeutic interfering particles against HIV: molecular parasites reducing viremia ; volume:9 ; number:1 ; day:14 ; month:10 ; year:2024 ; pages:1-3 ; date:12.2024
Signal transduction and targeted therapy ; 9, Heft 1 (14.10.2024), 1-3, 12.2024
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41392-024-02001-0
- URN
-
urn:nbn:de:101:1-2501012110335.600696844985
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gruell, Henning
- Odidika, Stanley
- Schommers, Philipp Frederik
- SpringerLink (Online service)
Other Objects (12)
Evolution of naturally arising SARS-CoV-2 defective interfering particles
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
Production of antiviral “OP7 chimera” defective interfering particles free of infectious virus
Cell culture-based production of defective interfering particles for influenza antiviral therapy
Cell culture-based production of influenza A virus-derived defective interfering particles
Mechanisms Contributing to Control of Viremia
Population dynamics of an RNA virus and its defective interfering particles in passage cultures
Interfering with sleep apnea
Clinical consequences of persistent low level viremia
In-depth characterization and cell culture-based production in influenza A virus defective interfering particles
Parasites
Parasites
Evolution of naturally arising SARS-CoV-2 defective interfering particles
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
Production of antiviral “OP7 chimera” defective interfering particles free of infectious virus
Cell culture-based production of defective interfering particles for influenza antiviral therapy
Cell culture-based production of influenza A virus-derived defective interfering particles
Mechanisms Contributing to Control of Viremia
Population dynamics of an RNA virus and its defective interfering particles in passage cultures
Interfering with sleep apnea
Clinical consequences of persistent low level viremia
In-depth characterization and cell culture-based production in influenza A virus defective interfering particles
Parasites
Parasites
Evolution of naturally arising SARS-CoV-2 defective interfering particles
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
Production of antiviral “OP7 chimera” defective interfering particles free of infectious virus
Cell culture-based production of defective interfering particles for influenza antiviral therapy
Cell culture-based production of influenza A virus-derived defective interfering particles
Mechanisms Contributing to Control of Viremia
Population dynamics of an RNA virus and its defective interfering particles in passage cultures
Interfering with sleep apnea
Clinical consequences of persistent low level viremia
In-depth characterization and cell culture-based production in influenza A virus defective interfering particles
Parasites